NGMD NuGen Medical Devices Inc.
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is based in Toronto, Canada.…
Industry Peers
Medical DevicesKey Statistics
About NuGen Medical Devices (CVE: NGMD)
›
NuGen Medical Devices (CVE: NGMD) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.
The shares were at 0.0150 CAD on 18 November 2026, down 62.5% over 52 weeks. Its 52-week range is 0.0150 CAD to 0.0450 CAD, and it trades at the bottom of that range.
Its market capitalisation is 3.41M CAD.
NuGen Medical Devices reports return on equity of 57.0% and revenue down 76.9% year over year.
Its debt exceeds its cash by 17.92M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 1 December 2026.